XML 50 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
The Business Cell Therapy Development and Manufacturing (Details)
3 Months Ended
Mar. 31, 2017
client
product
filing
Mar. 16, 2017
Mar. 11, 2016
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Equity Method Investment, Ownership Percentage     19.90%
Subsidiary, Ownership Interest by Parent   80.10% 80.10%
PCT Allendale, LLC [Member]      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Number Of Clients | client 100    
Number Of Products Produced | product 20,000    
PCT Allendale, LLC [Member] | United States And European Union [Member]      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Number Of Supported Regulatory Filings | filing 50